DNA2.0 today announced the availability of the company’s Bioinformatics Services, a range of custom computational solutions that can help quickly answer research questions and successfully move projects forward. This transparent, hourly fee-for-service enables researchers to enlist DNA2.0’s in-house expert capacity, eliminating the need for your own cumbersome bioinformatics infrastructure. DNA2.0 Bioinformatics Services consulting is ideal for small, nimble operations that benefit from instant access to bioinformatics expertise.
Access to efficient gene synthesis and increasingly refined gene-design tools has accelerated protein biochemistry research, as it enables a quick and powerful way to test computational protein structure-function predictions in the wet lab. Biochemical projects that used to require deep expertise in molecular biology and computational bioinformatics are increasingly accessible, and with DNA2.0 bioinformatics technology and expertise, mathematical and computational approaches are now within the grasp of any research entity, regardless of size or budget.
“Achieve your research goals using computationally intelligent techniques rather than brute force,” said Claes Gustafsson, cofounder and Chief Commercial Officer of DNA2.0. “DNA2.0 custom Bioinformatics Services offer you direct access to our years of expertise, providing an easy and affordable means of accessing sophisticated and time-saving bioinformatics results for routine use in your research endeavors.”
DNA2.0 can create a custom bioinformatics approach for any research program to ensure success. Key service offerings include:
- Data mining, machine learning and pattern recognition
- Sequence and structure alignment
- Gene finding and gene expression analysis
- Protein structure prediction
- Comparative genomics analysis
- Genome-wide functional association studies
About DNA2.0
DNA2.0 is the leading bioengineering solutions provider. Founded in 2003, DNA2.0 offers an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene design and synthesis processes and new protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Menlo Park, Calif. For more information, please visit www.DNA20.com.